Article Information
History
- July 11, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Srirupa Das, PhD*,1,
- Candice Dowell-Martino, BS2,
- Lisa Arrigo, MS1,
- Paul N. Fiedler, MD3 and
- Sandra Lobo, PhD, MBA4
- 1Department of Pathology Research, Nuvance Health, Danbury, CT 06810, USA
- 2Department of Pancreatic Research, Nuvance Health, Danbury, CT 06810, USA
- 3Department of Pathology, Nuvance Health, Danbury, CT 06810, USA
- 4Rudy L. Ruggles Biomedical Research Institute, Nuvance Health, Danbury, CT 06810, USA
- ↵*Corresponding Author: Srirupa Das, 131 West St, Building C, Danbury CT 06810.
Email:Srirupa.das{at}nuvancehealth.org; Tel: 203-739-8394; Fax: 203-739-8739
Posted July 11, 2020.
In-house modification and improvement of the CDC real-time PCR diagnostic assay for SARS-CoV-2 detection
